Carmen da Casa

Dr. Carmen da Casa

Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2019 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
PDF file
JBJuan Francisco B. Blanco
Juan Francisco B. Blanco
ADAgustin Diaz-Alvarez
Agustin Diaz-Alvarez
FMFrancisco R. Melchor
Francisco R. Melchor
CCCarmen da Casa
Carmen da Casa
DPDavid Pescador
David Pescador

1 July 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
LBLuis Bonet-Ponce
Luis Bonet-Ponce
SSSara Saez-Atienzar
Sara Saez-Atienzar
CCCarmen da Casa
Carmen da Casa
MFMiguel Flores-Bellver
Miguel Flores-Bellver
JBJorge M. Barcia
Jorge M. Barcia
MGMaria F Galindo
Maria F Galindo

16 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJuan F. Blanco
Juan F. Blanco
CCCarmen da Casa
Carmen da Casa
CPCarmen Pablos-Hernández
Carmen Pablos-Hernández
AGAlfonso González-Ramírez
Alfonso González-Ramírez
JJJosé Miguel Julián-Enríquez
José Miguel Julián-Enríquez
ADAgustín Díaz-Álvarez
Agustín Díaz-Álvarez
Purpose: The 30-day mortality rate after hip fracture surgery has been considered as an indirect indicator of the quality of care. The aim of this work is to analyse preoperative and postoperative factors potentially related to early 30-day mortality in patients over 65 undergoing hip fracture surgery. Methods: Prospective cohort study including all consecutive primary hip fracture patients over 65 admitted to Trauma and Orthopaedics department from January 1, 2018 to December 31, 2019. Bed-ridden, non- surgically treated patients, and high energy trauma or tumoral aetiology fractures were excluded. A total of 943 patients were eligible (attrition rate: 2.1%). Follow-up included 30-days after discharge. We noted the 30-day mortality after hip fracture surgery, analysing 130 potentially related variables including biodemographic, fracture-related, preoperative, and postoperative clinical factors. Qualitative variables were assessed by χ2, and quantitative variables by non-parametric tests. Odds ratio determined by binary logistic regression. We selected preventable candidate variables for multivariate risk assessment by logistic regression. Results: A total of 923 patients were enrolled (mean age 86.22±6.8, 72.9% women). The 30-day mortality rate was 6.0%. We noted significant increased mortality on men (OR = 2.381[1.371–4.136], p = 0.002), ageing patients (ORyear = 1.073[1.025–1.122], p = 0.002), and longer time to surgery (ORday = 1.183[1.039–1146], p<0.001), on other 20 preoperative clinical variables, like lymphopenia (lymphocyte count <103/μl, OR = 1.842[1.063–3.191], p = 0.029), hypoalbuminemia (≤3.5g/dl, OR = 2.474[1.316–4.643], p = 0.005), and oral anticoagulant intake (OR = 2.499[1.415–4.415], p = 0.002), and on 25 postoperative clinical variables, like arrhythmia (OR = 13.937[6.263–31.017], p<0.001), respiratory insufficiency (OR = 7.002[3.947–12.419], p<0.001), hyperkalaemia (OR = 10.378[3.909–27.555], p<0.001), nutritional supply requirement (OR = 3.576[1.894–6.752], p = 0.021), or early arthroplasty dislocation (OR = 6.557[1.206–35.640], p = 0.029). We developed a predictive model for early mortality after hip fracture surgery based on postoperative factors with 96.0% sensitivity and 60.7% specificity (AUC = 0.863). Conclusion: We revealed that not only preoperative, but also postoperative factors have a great impact after hip fracture surgery. The influence of post-operative factors on 30-day mortality has a logical basis, albeit so far they have not been identified or quantified before. Our results provide an advantageous picture of the 30-day mortality after hip fracture surgery.

22 February 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JBJuan Francisco B. Blanco
Juan Francisco B. Blanco
EVEva M. Villarón
Eva M. Villarón
DPDavid Pescador
David Pescador
CCCarmen da Casa
Carmen da Casa
VGVictoria Gómez
Victoria Gómez
FSFermin Sanchez-Guijo
Fermin Sanchez-Guijo
Posterolateral spinal fusion with autologous bone graft is considered the “gold standard” for lumbar degenerative disc disease (DDD) when surgical treatment is indicated. The potential role of mesenchymal stromal cells (MSCs) to replace the bone graft in this setting has not been fully addressed. To analyze the safety, feasibility and potential clinical efficacy of the implantation of autologous MSCs embedded with tricalcium phosphate as a therapeutic alternative to bone graft in patients with DDD during posterolateral spine fusion. Phase I/II single-arm prospective clinical trial. Eleven patients with monosegmental DDD at L4–L5 or L5–S1 level were included. Autologous bone marrow-derived MSC were expanded in our Good Manufacturing Practice (GMP) Facility and implanted during spinal surgery embedded in a tricalcium phosphate carrier. Monitoring of patients included a postoperative period of 12 months with four visits (after the 1st, 3rd, 6th, and 12th month), with clinical and radiological assessment that included the visual analog scale (VAS), the Oswestry disability index (ODI), the Short-Form Health Survey (SF-36), the vertebral fusion grade observed through a simple Rx, and the evaluation of possible complications or adverse reactions. In addition, all patients were further followed up to 5 years for outcome. Median age of patients included was 44 years (range 30–58 years), and male/female ratio was (6/5) L4–L5 and L5–S1 DDD was present five and six patients, respectively. Autologous MSCs were expanded in all cases. There were no adverse effects related to cell implantation. Regarding efficacy, both VAS and ODI scores improved after surgery. Radiologically, 80% of patients achieved lumbar fusion at the end of the follow-up. No adverse effects related to the procedure were recorded. The use of autologous MSCs for spine fusion in patients with monosegmental degenerative disc disease is feasible, safe, and potentially effective. no. EudraCT: 2010–018335-17 ; code Identifier: NCT01513694 ( clinicaltrials.gov ).

12 November 2015 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
LBLuis Bonet-Ponce
Luis Bonet-Ponce
SSSara Saez-Atienzar
Sara Saez-Atienzar
CCCarmen da Casa
Carmen da Casa
JSJavier Sancho-Pelluz
Javier Sancho-Pelluz
JBJorge M. Barcia
Jorge M. Barcia
MGMaria F Galindo
Maria F Galindo

1 August 2019 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
CCCarmen da Casa
Carmen da Casa
MHMARÍA DEL CARMEN PABLOS HERBÁNDEZ
MARÍA DEL CARMEN PABLOS HERBÁNDEZ
AGAlfonso González-Ramírez
Alfonso González-Ramírez
JJJosé Miguel Julián-Enriquez
José Miguel Julián-Enriquez
JBJuan Francisco B. Blanco
Juan Francisco B. Blanco
The management of hip fractures is nowadays mainly performed in Orthogeriatric Units, one of whose fundamental tools is the application of geriatric scores. The purpose of this study is to establish the potential usefulness of Barthel Index, Katz Index, Lawton-Brody Index and Physical Red Cross Scale geriatric scores as predictors of survival rate and readmission rate in older patients after hip fracture surgery. We designed a prospective single-center observational study, including 207 older adults over age 65 who underwent hip fracture surgery in the first half of 2014 and followed up to September 2018. Cumulative survival and readmission rates were analyzed by Kaplan-Meier; group comparison, by Log-Rank and hazard ratio, by Cox regression. We found statistical differences (p < 0.001) for cumulative survival rate by every geriatric score analyzed (BI HR = 0.98 [0.97,0.99]; KI HR = 1.24 [1.13–1.37]; LBI HR = 1.25 [1.16, 1.36]; PCRS HR = 1.67 [1.37,2.04]). Furthermore, we could determinate an inflection point for survival estimation by Barthel Index (BI 0–55/60–100*, p < 0.001, HR = 2.37 [1.59,3.53]), Katz Index (KI A-B*/C-G, p < 0.001, HR = 2.66 [1.80, 3.93], and Lawton-Brody Index (LBI 0–3/4–8*, p < 0.001, HR = 3.40 [2.09,5.25]). We reveal a correlation of the Charlson Index (p = 0.002) and Katz Index (p = 0.041) with number of readmissions for the study period. The geriatric scores analyzed are related to the cumulative survival rate after hip fracture surgery for more than 4 years, independently of other clinical and demographic factors. Katz Index in combination with Charlson Index could also be a potential predictor of the number of readmissions after surgery for hip fracture patients.